Emerging as a result of Indivumed’s twenty years of success and innovation as a leading precision oncology company, Indivumed Therapeutics is fully focused on AI-driven biomarker and therapeutic target discovery, target validation, preclinical drug development, and clinical validation. A global clinical network of leading cancer clinics and hospitals in Europe, The Americas, and Asia enables the standardized collection of biospecimen and clinical data in a comprehensive multi-omics database.
Falkenried 88, Haus D
Biotechnology / Pharma, Services
contract research & development, diagnostics, drug discovery / development / production / retail, enabling technologies, other areas